tiprankstipranks
Pyxis Oncology (PYXS)
NASDAQ:PYXS
US Market

Pyxis Oncology (PYXS) Income Statement

Compare
440 Followers

Pyxis Oncology Income Statement

Last quarter (Q3 2024), Pyxis Oncology's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Pyxis Oncology's net income was $-21.20M. See Pyxis Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -2.00M$ -1.84M$ -1.25M$ -444.00K$ 0.00
Operating Expenses
$ 82.20M$ 123.48M$ 69.72M$ 12.89M$ 2.88M
Depreciation and Amortization
$ 2.00M$ 1.84M$ 1.25M$ 444.00K$ 2.88M
EBITDA
$ -78.49M$ -122.77M$ -69.07M$ -12.43M$ 0.00
Operating Income
$ -82.20M$ -123.48M$ -69.72M$ -12.89M$ -2.88M
Other Income/Expenses
$ 8.41M$ 2.76M$ -6.26M$ 66.00K$ 107.00K
Pretax Income
$ -73.79M$ -120.72M$ -75.97M$ -12.83M$ -2.77M
Net Income
$ -73.79M$ -117.95M$ -81.54M$ -12.76M$ -2.67M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.85$ -3.57$ -2.53$ -0.37$ -0.08
Diluted EPS
$ -1.85$ -3.57$ -2.53$ -0.37$ -0.08
Weighted Average Shares Outstanding
39.90M 33.03M 32.22M 34.31M 34.31M
Weighted Average Shares Outstanding (Diluted)
39.90M 33.03M 32.22M 34.31M 34.31M
Currency in USD

Pyxis Oncology Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis